Advertisement

Topics

"Ovid Therapeutics Reports Third Quarter 2017 Financial Results" Drugs and Medication Database

20:25 EDT 18th March 2019 | BioPortfolio

Here are the most relevant "Ovid Therapeutics Reports Third Quarter 2017 Financial Results" Drugs and Medications that we have found in our database.

More Information about "Ovid Therapeutics Reports Third Quarter 2017 Financial Results" on BioPortfolio

We have published hundreds of Ovid Therapeutics Reports Third Quarter 2017 Financial Results news stories on BioPortfolio along with dozens of Ovid Therapeutics Reports Third Quarter 2017 Financial Results Clinical Trials and PubMed Articles about Ovid Therapeutics Reports Third Quarter 2017 Financial Results for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ovid Therapeutics Reports Third Quarter 2017 Financial Results Companies in our database. You can also find out about relevant Ovid Therapeutics Reports Third Quarter 2017 Financial Results Drugs and Medications on this site too.

Showing "Ovid Therapeutics Reports Third Quarter 2017 Financial Results" Drugs and Medications 1–25 of 57

Probably Relevant

Kynamro [kastle therapeutics, llc]

NA

Possibly Relevant

Olopatadine hydrochloride [somerset therapeutics, llc]

OLOPATADINE Hydrochloride Ophthalmic Solution USP, 0.1%Somerset Therapeutics, LLC

Epinephrine hypospray(r) [langford research institute]

Epinephrine HypoSpray

Oxygen [sky oxygen]

Oxygen Labels

Oxygen [praxair mexico, s. de r.l. de c.v]

NA

Baxdela [melinta therapeutics, inc]

These highlights do not include all the information needed to use BAXDELA safely and effectively. See full prescribing information for BAXDELA. BAXDELA (delafloxacin) tablets, for oral use BAXDELA (delafloxacin) for injection, for intravenous use Initial

Prednisone [northwind pharmaceuticals]

NA

Oxygen [breathe easy therapeutics, inc]

NA

Diclofenac sodium delayed release [cambridge therapeutics technologies, llc]

Diclofenac Sodium

Olopatadine hydrochloride [a-s medication solutions]

OLOPATADINE Hydrochloride Ophthalmic Solution USP, 0.1%Somerset Therapeutics, LLC

Sentradine [physician therapeutics llc]

Sentradine

Denti-care [ar medicom inc]

Denti-Care Denti-Foam Topical Fluoride Foam Orange 1.23% Fluoride Ions

Denti-care [ar medicom inc]

Denti-Care Denti-Foam Topical Fluoride Foam grape 1.23% Fluoride Ions

Denti-care [ar medicom inc]

Denti-Care Denti-Foam Topical Fluoride Foam Bubble Gum 1.23% Fluoride Ions

Denti-care [ar medicom inc]

Denti-Care Denti-Foam Topical Fluoride Foam Raspberry 1.23 % Fluoride Ions

Denti-care [ar medicom inc]

Denti-Care Denti-Foam 1.76% Topical Sodium Fluoride Foam Strawberry

Folotyn [allos therapeutics]

These highlights do not include all the information needed to use FOLOTYN safely and effectively. See full prescribing information for FOLOTYN.FOLOTYN (pralatrexate injection), for intravenous use Initial U.S. Approval: 2009

Urised [key therapeutics]

Urised

Ergomar [tersera therapeutics, llc]

Ergomar Sublingual Tablets, 2 mg

Eskata [aclaris therapeutics, inc.]

These highlights do not include all the information needed to use ESKATA™ safely and effectively. See full prescribing information for ESKATA™. ESKATA™ (hydrogen peroxide) topical solutionInitial U.S. Approval: 2017

Denti-care denti-foam [amd medicom inc]

10037-RB Raspberry Foam DentiCare Pro-Foam 2.72 % Topical Sodium Fluoride

Tobramycin [somerset therapeutics, llc]

Rx OnlyFor Topical Ophthalmic Use Only

Sustol [heron therapeutics]

These highlights do not include all the information needed to use SUSTOL safely and effectively. See full prescribing information for SUSTOL.SUSTOL (granisetron) extended-release injection, for subcutaneous useInitial U.S. Approval: 1993

Multi-vitamin fluoride drops [h.j. harkins company, inc.]

Unknown Title

Tobramycin [nucare pharmaceuticals,inc.]

Rx Only For Topical Ophthalmic Use Only



Advertisement
Quick Search
Advertisement
Advertisement